Clinical Trial Update: Line Versus Spot Ablation in Persistent Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluates line-based versus spot ablation strategies for persistent atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN